Ranibizumab for Neovascularization in Sickle Cell Retinopathy
Clinical trial NCT00618644 · WITHDRAWN
Trial details
- NCT number
- NCT00618644
- Sponsor
- Kresge Eye Institute
- Status
- WITHDRAWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-01
- Primary completion
- 2011-06-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.